A Novel Missense Variant of the ABCD1 Gene in X‐Linked Adrenoleukodystrophy in Chinese Family

Guardado en:
Detalles Bibliográficos
Publicado en:Molecular Genetics & Genomic Medicine vol. 13, no. 10 (Oct 1, 2025)
Autor principal: Fu, Hongxia
Otros Autores: Han, Lu, Liu, Xianhong, He, Bin, He, Pei, Hu, Junjian
Publicado:
John Wiley & Sons, Inc.
Materias:
Acceso en línea:Citation/Abstract
Full Text
Full Text - PDF
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

MARC

LEADER 00000nab a2200000uu 4500
001 3264787835
003 UK-CbPIL
022 |a 2324-9269 
024 7 |a 10.1002/mgg3.70148  |2 doi 
035 |a 3264787835 
045 0 |b d20251001 
084 |a 239828  |2 nlm 
100 1 |a Fu, Hongxia  |u Department of Neurology, SSL, Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Guangdong Medical University, Dongguan, China 
245 1 |a A Novel Missense Variant of the ABCD1 Gene in X‐Linked Adrenoleukodystrophy in Chinese Family 
260 |b John Wiley & Sons, Inc.  |c Oct 1, 2025 
513 |a Journal Article 
520 3 |a ABSTRACT Background We identified a novel ABCD1 variant (c.773T>G, p.Leu258Arg, NM_000033.4) in a Chinese pedigree affected by X‐linked adrenoleukodystrophy (X‐ALD). This missense variant in exon 1 is predicted to be pathogenic and likely constitutes the genetic basis of the disease phenotype in this family. Methods ABCD1 gene sequencing was performed in the Chinese pedigree. The pathogenicity of identified variants was assessed using computational prediction tools. Subcellular localization studies were conducted, and very‐long‐chain fatty acid (VLCFA) levels were quantified in patient‐derived samples. Results Sequencing analysis identified a hemizygous missense variant in the ABCD1 gene (c.773T>G; p.Leu258Arg). In silico pathogenicity prediction using SIFT and PolyPhen‐2 algorithms classified the p.Leu258Arg substitution as deleterious. Functional characterization revealed that the p.Leu258Arg variant impairs the peroxisomal membrane localization of the ABCD1 protein. Consistent with the established role of ABCD1 in peroxisomal β‐oxidation, individuals harboring this variant exhibited significantly elevated serum levels of VLCFA. Specifically, the C26:0/C22:0 ratio was elevated 2.8‐fold compared to control values, confirming impaired VLCFA metabolism. Conclusion In accordance with the “Standards and Guidelines for the Interpretation of Sequence Variants” established by the American College of Medical Genetics and Genomics (ACMG), we assessed the pathogenicity of the novel ABCD1 gene variant c.773T>G. This variant meets the following ACMG evidence criteria: PM1 (located within a critical functional domain or mutational hotspot known to lack benign variation); PM2 (absent or observed at very low frequency in population databases e.g., gnomAD, EXAC, 1000 Genomes); PP3 (multiple in silico prediction tools consistently suggest a deleterious effect on the gene or gene product). Integrating this evidence (PM1 + PM2 + PP3), the variant is classified as likely pathogenic based on ACMG guidelines. Experimental data from this study further substantiate the pathogenicity of the c.773T>G variant located in exon 1 of the ABCD1 gene. This finding broadens the spectrum of known pathogenic mutations in ABCD1 associated with X‐ALD and provides crucial information for the molecular diagnosis of affected patients. 
651 4 |a United States--US 
653 |a Guidelines 
653 |a Sequence analysis 
653 |a Hypothesis testing 
653 |a Memory 
653 |a Mutation 
653 |a Pathogenicity 
653 |a Phenotypes 
653 |a Genetic counseling 
653 |a Oxidation 
653 |a Localization 
653 |a Ethics 
653 |a Proteins 
653 |a Pathogens 
653 |a Hormone replacement therapy 
653 |a Encephalitis 
653 |a Mutation hot spots 
653 |a Serum levels 
653 |a Predictions 
653 |a Gene sequencing 
653 |a Autoimmune diseases 
653 |a Magnetic resonance imaging 
653 |a Genetics 
653 |a Adrenoleukodystrophy 
653 |a Pedigree 
653 |a Very Low Frequencies 
653 |a Software 
653 |a Social 
700 1 |a Han, Lu  |u Department of Central Laboratory, SSL, Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Guangdong Medical University, Dongguan, China 
700 1 |a Liu, Xianhong  |u The Center for Precision Medicine, SSL, Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Guangdong Medical University, Dongguan, China 
700 1 |a He, Bin  |u Department of Central Laboratory, SSL, Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Guangdong Medical University, Dongguan, China 
700 1 |a He, Pei  |u Department of Obstetrics and Gynaecology, The Center for Reproductive Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China 
700 1 |a Hu, Junjian  |u Department of Central Laboratory, SSL, Central Hospital of Dongguan City, Affiliated Dongguan Shilong People's Hospital of Guangdong Medical University, Dongguan, China 
773 0 |t Molecular Genetics & Genomic Medicine  |g vol. 13, no. 10 (Oct 1, 2025) 
786 0 |d ProQuest  |t Biological Science Database 
856 4 1 |3 Citation/Abstract  |u https://www.proquest.com/docview/3264787835/abstract/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text  |u https://www.proquest.com/docview/3264787835/fulltext/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch 
856 4 0 |3 Full Text - PDF  |u https://www.proquest.com/docview/3264787835/fulltextPDF/embedded/7BTGNMKEMPT1V9Z2?source=fedsrch